Pharma

U.S. Pharma Manufacturing Surges with $270B Investments
Manufacturing U.S. Pharma Manufacturing Surges with $270B Investments

A powerful wave of growth is sweeping through the U.S. pharmaceutical manufacturing industry, driven by significant financial commitments from leading companies. In a landscape evolving with staggering demand, pharmaceutical giants like Johnson & Johnson and Eli Lilly are spearheading this

Can Trump's Policies Revive U.S. Pharma Manufacturing?
Manufacturing Can Trump's Policies Revive U.S. Pharma Manufacturing?

In the aftermath of the Trump administration, the pharmaceutical industry is left navigating a complex landscape shaped by initiatives aimed at fostering domestic manufacturing. Intended to bolster the United States’ pharmaceutical production capabilities, these policies introduced through e

Novo Nordisk CEO Steps Down Amid Market and Supply Challenges
Management Novo Nordisk CEO Steps Down Amid Market and Supply Challenges

The sudden exit of Lars Fruergaard Jørgensen, Novo Nordisk's CEO, marks a pivotal moment in the company's history, with his departure underscoring the strategic challenges faced by this pharmaceutical giant. After more than thirty years within the company, including eight years at the

Are Pharma Labs Ready for AI-Driven Transformation?
Manufacturing Are Pharma Labs Ready for AI-Driven Transformation?

Kwame Zaire is a distinguished leader in the field of manufacturing, focusing on the intersection of electronics, equipment, and production management. Known for his insights into predictive maintenance and quality and safety enhancement, Kwame is at the forefront of driving technological

Proactive Measures to Navigate Pharma Regulatory Challenges
Manufacturing Proactive Measures to Navigate Pharma Regulatory Challenges

Imagine a leading pharmaceutical firm on the brink of losing millions due to a recent citation by the FDA, not for a defect in the product's formulation but inadequate storage conditions. This isn't just a hypothetical scenario—it's a reality faced by numerous companies striving to a

Will Trump's FDA Order Revolutionize U.S. Drug Manufacturing?
Management Will Trump's FDA Order Revolutionize U.S. Drug Manufacturing?

In a significant move aimed at reshaping the landscape of U.S. drug manufacturing, President Donald Trump signed an executive order on May 5, 2025. This directive mandates the Food and Drug Administration to accelerate the creation of new drug manufacturing facilities within the United States. At

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later